Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.052 | 0.6 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.6 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |